Alcoholic liver disease and exacerbation by malnutrition and infections: What animal models are currently available?

Annals of the New York Academy of Sciences

Volumn 1216, Issue 1, 2011, Pages 41-49

  Bergheim, Ina ^a   Eagon, Patricia K ^b   Dooley, Steven ^c   Breitkopf Heinlein, Katja ^c  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alcohol; Cyp2E1; Diet; Fat; Liver; TGF

Indexed keywords

ALCOHOL; CARBONYL IRON; CYTOCHROME P450 2E1; ENDOTOXIN; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA;

ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CHRONIC HEPATITIS; DISEASE EXACERBATION; ENDOTOXEMIA; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HUMAN; IRON OVERLOAD; LIPID DIET; LIVER CELL; MALLORY BODY; MALNUTRITION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OAT; OBESITY; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALIA; HEPATITIS C VIRUS;

EID: 79251477852     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05833.x     Document Type: Article

References (75)

1. Tsukamoto, H., K. Machida, A. Dynnyk & H. Mkrtchyan 2009. Second hit" models of alcoholic liver disease. Semin. Liver Dis. 29: 178-187.
2. Leo, M.A. & C.S. Lieber 1983. Hepatic fibrosis after long-term administration of ethanol and moderate vitamin A supplementation in the rat. Hepatology 3: 1-11.
3. Tsukamoto, H. et al 1995. Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest. 96: 620-630.
4. Tsukamoto, H., G. Lew, E.C. Larkin, et al 1984. Hepatic origin of triglycerides in fatty livers produced by the continuous intragastric infusion of an ethanol diet. Lipids 19: 419-422.
5. Sadrzadeh, S.M., A.A. Nanji & P.L. Price 1994. The oral iron chelator, 1, 2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats. J. Pharmacol. Exp. Ther. 269: 632-636.
6. Chen, A. 2002. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells. Biochem. J. 368: 683-693.
7. Friedman, S.L. 2008. Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669.
8. Dooley, S. et al 2008. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 135: 642-659.
9. Ciuclan, L. et al 2010. TGF-beta enhances alcohol dependent hepatocyte damage via down-regulation of alcohol dehydrogenase I. J. Hepatol. 52: 407-416.
10. Morgan, K., S.W. French & T.R. Morgan 2002. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 36: 122-134.
11. Keshavarzian, A. et al 2009. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J. Hepatol. 50: 538-547.
12. Szabo, G. & S. Bala 2010. Alcoholic liver disease and the gut-liver axis. World J. Gastroenterol. 16: 1321-1329.
13. Paik, Y.H. et al 2003. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37: 1043-1055.
14. Keshavarzian, A. et al 1999. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am. J. Gastroenterol. 94: 200-207.
15. Bigatello, L.M. et al 1987. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am. J. Gastroenterol. 82: 11-15.
16. Keshavarzian, A. et al 2001. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J. Pharmacol. Exp. Ther. 299: 442-448.
17. Forsyth, C.B. et al 2009. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 43: 163-172.
18. Nanji, A.A., U. Khettry & S.M. Sadrzadeh 1994. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc. Soc. Exp. Biol. Med. 205: 243-247
19. Osman, N. et al 2006. Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterol. 6: 31.
20. Stadlbauer, V. et al 2008. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J. Hepatol. 48: 945-951.
21. Adawi, D., S. Ahrne & G. Molin 2001. Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model. Int. J. Food Microbiol. 70: 213-220.
22. Chiva, M. et al 2002. Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J. Hepatol. 37: 456-462.
23. Liu, Q. et al 2004. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39: 1441-1449.
24. Purohit, V., D. Russo & P.M. Coates 2004. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium. Alcohol 34: 3-8.
25. Bellentani, S. & C. Tiribelli 2001. The spectrum of liver disease in the general population: lesson from the Dionysos study. J. Hepatol. 35: 531-537.
26. Naveau, S. et al 1997. Excess weight risk factor for alcoholic liver disease. Hepatology 25: 108-111.
27. Raynard, B. et al 2002. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 35: 635-638.
28. Mayer, J., M.W. Bates & M.M. Dickie 1951. Hereditary diabetes in genetically obese mice. Science 113: 746-747.
29. Mayer, J., M.M. Dickie, M.W. Bates & J.J. Vitale 1951. Free selection of nutrients by hereditarily obese mice. Science 113: 745-746.
30. Chalasani, N. et al 2003. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am. J. Gastroenterol. 98: 2771-2776.
31. Yang, S.Q., H.Z. Lin, M.D. Lane, et al 1997. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. USA 94: 2557-2562.
32. Faggioni, R. et al 1999. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am. J. Physiol. 276: R136-R142.
33. Brix, A.E. et al 2002. Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse. Mol. Genet. Metab. 75: 219-226.
34. Wortham, M., L. He, M. Gyamfi, et al 2008. The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet. Dig. Dis. Sci. 53: 2761-2774.
35. Masaki, T. et al 2004. Obesity in insulin receptor substrate-2-deficient mice: disrupted control of arcuate nucleus neuropeptides. Obes. Res. 12: 878-885.
36. Anstee, Q.M. & R.D. Goldin 2006. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 87: 1-16.
37. Leclercq, I.A. et al 2000. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J. Clin. Invest. 105: 1067-1075.
38. Rivera, C.A. et al 2007. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J. Hepatol. 47: 571-579.
39. Larter, C.Z., M.M. Yeh, J. Williams, et al 2008. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes. J. Hepatol. 49: 407-416.
40. Rinella, M.E. et al 2008. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J. Lipid. Res. 49: 1068-1076.
41. Buettner, R., J. Scholmerich & L.C. Bollheimer 2007. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 15: 798-808.
42. Yoshimatsu, M. et al 2004. Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process. Int. J. Exp. Pathol. 85: 335-343.
43. Omagari, K. et al 2008. Effects of a long-term high-fat diet and switching from a high-fat to low-fat, standard diet on hepatic fat accumulation in Sprague-Dawley rats. Dig. Dis. Sci. 53: 3206-3212.
44. Varela-Rey, M. et al 2009. Non-alcoholic steatohepatitis and animal models: understanding the human disease. Int. J. Biochem. Cell Biol. 41: 969-976.
45. Li, Z. et al 2004. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. Hepatology 40: 434-441.
46. de Oliveira, C.P. et al 2008. Prevention and reversion of nonalcoholic steatohepatitis in OB/OB mice by S-nitroso-N-acetylcysteine treatment. J. Am. Coll. Nutr. 27: 299-305.
47. Nanji, A.A. 2004. Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 34: 21-25.
48. Tipoe, G.L. et al 2009. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD). Histol. Histopathol. 24: 1161-1169.
49. Bergheim, I. et al 2008. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J. Hepatol. 48: 983-992.
50. Spruss, A. et al 2009. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50: 1094-1104.
51. Feldstein, A.E. et al 2003. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J. Hepatol. 39: 978-983.
52. Kanuri, G. et al 2009. Cinnamon extract protects against acute alcohol-induced liver steatosis in mice. J. Nutr. 139: 482-487.
53. Ouyang, X. et al 2008. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 48: 993-999.
54. Assy, N. et al 2008. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can. J. Gastroenterol. 22: 811-816.
55. Thuy, S. et al 2008. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J. Nutr. 138: 1452-1455.
56. Gäbele E, D.K., C Dorn & C. Hellerbrand 2010. A new model of synergistic effects of alcohol and high-fat diet on hepatic injury. Z. Gastroenterol. 48: 141.
57. Libbrecht, L., V. Desmet, B. Van Damme & T. Roskams 2000. Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate? J. Pathol. 192: 373-378.
58. Lowes, K.N., B.A. Brennan, G.C. Yeoh & J.K. Olynyk 1999. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am. J. Pathol. 154: 537-541.
59. Roskams, T. et al 2003. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am. J. Pathol. 163: 1301-1311.
60. Libbrecht, L. & T. Roskams 2002. Hepatic progenitor cells in human liver diseases. Semin. Cell Dev. Biol. 13: 389-396
61. Jung, Y. et al 2008. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology 134: 1532-1543.
62. Jensen, K. & C. Gluud 1994. The Mallory body: morphological, clinical and experimental studies (Part 1 of a literature survey). Hepatology 20: 1061-1077.
63. Zhang-Gouillon, Z.Q. et al 1998. Mallory body formation by ethanol feeding in drug-primed mice. Hepatology 27: 116-122.
64. Sahai, A. et al 2004. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G1035-G1043.
65. Mueller, S., G. Millonig & H.K. Seitz 2009. Alcoholic liver disease and hepatitis C: a frequently underestimated combination. World J. Gastroenterol. 15: 3462-3471.
66. Lederer, S.L. et al 2006. Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis. Virol. J. 3: 98.
67. Piasecki, B.A. et al 2004. Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology 40: 892-899.
68. Otani, K. et al 2005. Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 128: 96-107.
69. Mas, V.R., R. Fassnacht, K.J. Archer & D. Maluf 2010. Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. Mol. Med. 16: 287-297.
70. Perlemuter, G. et al 2003. Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model. J. Hepatol. 39: 1020-1027.
71. Cook, R.T. 1998. Alcohol abuse, alcoholism, and damage to the immune system-a review. Alcohol Clin. Exp. Res. 22: 1927-1942.
72. Cerny, A. & F.V. Chisari 1999. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 30: 595-601.
73. Pianko, S., S. Patella, G. Ostapowicz, et al 2001. Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection. J. Viral. Hepat. 8: 406-413.
74. Rigamonti, C. et al 2003. Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Hepatology 38: 42-49.
75. Ploss, A. & C.M. Rice 2009. Towards a small animal model for hepatitis C. EMBO Rep. 10: 1220-1227.